D
Matinas BioPharma Holdings, Inc. MTNB
$2.13 $0.3922.41% AMEX
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 14.42% 13.63% -5.71% 0.61% -10.85%
Total Depreciation and Amortization -22.73% -9.66% 3.29% 4.10% 4.35%
Total Amortization of Deferred Charges -- 30.77% -- -100.00% -100.00%
Total Other Non-Cash Items 104.97% 37.08% 48.83% -17.29% -15.79%
Change in Net Operating Assets -241.54% -3.57% -107.86% -675.00% 67.72%
Cash from Operations 38.24% 28.52% -3.97% -13.04% -14.95%
Capital Expenditure -- -- -- 100.00% 96.76%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 224.98% -42.15% -31.59% 11.12% -79.73%
Cash from Investing 226.66% -41.12% -30.46% 13.95% -79.16%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -25.00% -25.00% 28.57% 54.55% 69.23%
Issuance of Common Stock -100.00% 16,918.52% -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -65.36% 21,436.00% 131,157.14% 83,500.00% 71,176.92%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 141.78% 225.39% 222.22% 181.53% -742.53%